IN THE HIGH COURT OF DELHI AT NEW DELHI
MINI PUSHKARNA, J.
Zydus Healthcare Limited & Ors. – Appellants
Versus
Alder Biochem Private Limited – Respondent
CS(COMM) 516 of 2023, I.A. 14145 of 2023 & I.A. 3116 of 2024
Decided on : 13-11-2024
(A) Trade Marks Act, 1999 - Section 29 - Infringement of registered trademark - Plaintiffs sought interim injunction against the defendant for using the mark 'ALDER BIOCHEM' which is deceptively similar to the plaintiffs' registered trademark 'BIOCHEM' - The plaintiffs established prior use and goodwill in the mark 'BIOCHEM' since 1959 - The defendant's mark was found to be visually, phonetically, and structurally similar, likely to cause confusion among consumers - Balance of convenience favored the plaintiffs as confusion in pharmaceutical products can be life-threatening. (Paras 25 and 26)
(B) Trademark Infringement - The court emphasized that the dominant features of a trademark attract consumer attention and should be protected - The mere addition of a prefix does not negate the likelihood of confusion. (Paras 10 and 12)
JUDGMENT :
MINI PUSHKARNA, J:
I.A. 14145/2023 (Application under Order XXXIX Rules 1 & 2 read with Section 151 CPC, 1908)
1. The present application has been filed on behalf of the plaintiffs under Order XXXIX Rules 1 and 2 of Code of Civil Procedure, 1908 (“CPC”) seeking interim injunction for restraining the defendant from manufacturing, selling, offering for sale, advertising and/or promoting by using the mark/trade name “ALDER BIOCHEM” and any other mark/trade name/label/device that contains the trademark BIOCHEM.
2. The facts as pleaded by the plaintiffs, are as follows:
2.1 The present suit relates to the defendant’s adoption of the identical and deceptively similar mark “ALDER BIOCHEM” and the trade name “Alder Biochem Pvt. Ltd.” in relation to pharmaceutical goods, which amounts to infringement of the plaintiffs” registered trademark “BIOCHEM” under Section 29 of the Trade Marks Act, 1999 (“Trade Marks Act”), as well as passing off.
2.2 The trademark BIOCHEM (device) is registered in the name of plaintiff no.1 and is being used by the plaintiff nos. 1 and 3 on pharmaceutical products. The trademark BIOCHEM was coined and first adopted by the entity named, Biochem Pharmaceutical Industries, in the year 1959. Thereafter, in the year 2004 Biochem Pharmaceutical Industries converted from a partnership to a company under the name Biochem Pharmaceutical Industries Ltd., which was subsequently amalgamated with Zydus Healthcare Ltd., plaintiff no.1 herein. Consequently, all the intellectual property of Biochem Pharmaceutical Industries, including, the trademark BIOCHEM, were transferred to the plaintiff no.1. Thus, plaintiff no.1 is presently the registered proprietor of the trademark BIOCHEM.
2.3 The details of the trade registrations of BIOCHEM, in the name of plaintiff no.1, are as follows:
2.4 The trademarks of the plaintiffs are valid and subsisting as on date.
2.5 In May, 2022, the plaintiff no.1’s representatives in Delhi came across an application filed by the defendant for registration of the mark “ALDER BIOCHEM” under Application No. 4491294 in Class 5, claiming use since 01st January, 2019. Plaintiff no.1 immediately issued a Cease and Desist Legal Notice dated 04th May, 2022 to the defendant. On 01st August, 2022, the defendant issued a reply in response to the plaintiff no.1’s legal notice, refuting the plaintiff no.1’s averments. The defendant stated that it commenced usage of the trade name Alder Biochem Pvt. Ltd. in the year 2016, though the defendant’s trademark application claimed use of the impugned mark since January, 2019.
2.6 Thereafter, in the last week of April, 2023, the plaintiff no.1’s representatives came across another application filed by the defendant for registration of the device mark Alder Biochem under application no. 4495449 in Class 5. The said trademark application claims usage since 01st January, 2019. The plaintiff no.1 immediately filed a notice of opposition dated 28th April, 2023 against the said trademark application, which opposition proceedings, are presently pending before the Trade Marks Registry.
2.7 Plaintiff no.1 and its wholly owned subsidiary-plaintiff no. 3, has been using the trademark BIOCHEM on more than 500 of their pharmaceutical products. The said trademark BIOCHEM has generated huge reputation and goodwill for the plaintiffs over several years. The defendant had subsequently commenced usage of the mark BIOCHEM as part of its infringing trade name ALDER BIOCHEM Pvt. Ltd.
2.8 The defendant has also applied for registration of the infringing word mark ALDER BIOCHEM under Application No. 4491294 in Class 5 for pharmaceutical products on 24th April, 2020, claiming user date since 01st January, 2019. The defendant has also applied for registration of the infringing device mark ALDER BIOCHEM in Class 5 for pharmaceutical products on 04th May, 2020, claiming user date since 01st January, 2019.
2.9 The impugned mark/name ALDER BIOCHEM of the defendant amounts to a brazen violation of the
The use of a deceptively similar mark in the pharmaceutical industry can lead to confusion, warranting injunction to protect the registered trademark.
The court emphasized that the likelihood of confusion due to phonetic, visual, and structural similarities between registered trademarks is critical, particularly in the pharmaceutical industry, warr....
Generic and descriptive terms in trademarks cannot be exclusively claimed, and likelihood of confusion must be assessed holistically from the average consumer's perspective.
Important Point :The use of a trademark that is phonetically and visually similar to a registered trademark can lead to confusion, constituting infringement, especially when dishonest conduct is evid....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.